Arterial thrombosis and second cancer in MPNs
Open Access
- 30 January 2020
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 135 (5) , 301-302
Abstract
In this issue of Blood, De Stefano and colleagues report that the occurrence of an arterial thrombotic event during follow-up after the diagnosis of a PhiladelpKeywords
This publication has 10 references indexed in Scilit:
- Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control studyBlood, 2020
- Second cancers in MPN: Survival analysis from an international studyAmerican Journal of Hematology, 2019
- Highly Reduced Survival in ET and PV Patients with Vascular Complications during Follow-up - Real World Data from the Swedish MPN RegistrBlood, 2019
- Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirinLeukemia, 2019
- Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control studyLeukemia, 2019
- A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasmsBMC Cancer, 2019
- Effect of Aspirin on All-Cause Mortality in the Healthy ElderlyNew England Journal of Medicine, 2018
- Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative NeoplasmsAnnals of Internal Medicine, 2018
- Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNetLeukemia, 2018
- A population-based analysis of second malignancies among patients with myeloproliferative neoplasms in the SEER databaseLeukemia & Lymphoma, 2015